Correction: Serum 25-hydroxyvitamin D concentrations 40 ng/ml are associated with >65% lower cancer risk: Pooled analysis of randomized trial and prospective cohort study (PLoS ONE (2016) 11: 4 (e0152441) DOI: 10.1371/journal.pone.0152441)

Sharon L. McDonnell; Carole Baggerly; Christine B. French; Leo L. Baggerly; Cedric F. Garland; Edward D. Gorham; Joan M. Lappe; Robert P. Heaney

doi:10.1371/journal.pone.0201078

Correction

Serum 25-hydroxyvitamin D concentrations 40 ng/ml are associated with >65% lower cancer risk: Pooled analysis of randomized trial and prospective cohort study (PLoS ONE (2016) 11: 4 (e0152441) DOI: 10.1371/journal.pone.0152441)

Sharon L. McDonnell, Carole Baggerly, Christine B. French, Leo L. Baggerly, Cedric F. Garland, Edward D. Gorham, Joan M. Lappe, Robert P. Heaney

College of Nursing

Research output: Contribution to journal › Comment/debate

Abstract

The Data Availability statement for this paper is incorrect. The correct statement is: The data are available through the Zenodo repository and can be accessed at https://doi.org/10.5281/zenodo.1299364.

Original language	English (US)
Article number	e0201078
Journal	PLoS One
Volume	13
Issue number	7
DOIs	https://doi.org/10.1371/journal.pone.0201078
State	Published - Jul 1 2018

Fingerprint

risk analysis

Risk analysis

cohort studies

Cohort Studies

Availability

Prospective Studies

neoplasms

Serum

Neoplasms

25-hydroxyvitamin D

4-iodo-2,5-dimethoxyphenylisopropylamine

All Science Journal Classification (ASJC) codes

Biochemistry, Genetics and Molecular Biology(all)
Agricultural and Biological Sciences(all)

Cite this

McDonnell, S. L., Baggerly, C., French, C. B., Baggerly, L. L., Garland, C. F., Gorham, E. D., ... Heaney, R. P. (2018). Correction: Serum 25-hydroxyvitamin D concentrations 40 ng/ml are associated with >65% lower cancer risk: Pooled analysis of randomized trial and prospective cohort study (PLoS ONE (2016) 11: 4 (e0152441) DOI: 10.1371/journal.pone.0152441). PLoS One, 13(7), [e0201078]. https://doi.org/10.1371/journal.pone.0201078

Correction : Serum 25-hydroxyvitamin D concentrations 40 ng/ml are associated with >65% lower cancer risk: Pooled analysis of randomized trial and prospective cohort study (PLoS ONE (2016) 11: 4 (e0152441) DOI: 10.1371/journal.pone.0152441). / McDonnell, Sharon L.; Baggerly, Carole; French, Christine B.; Baggerly, Leo L.; Garland, Cedric F.; Gorham, Edward D.; Lappe, Joan M.; Heaney, Robert P.

In: PLoS One, Vol. 13, No. 7, e0201078, 01.07.2018.

Research output: Contribution to journal › Comment/debate

McDonnell, SL, Baggerly, C, French, CB, Baggerly, LL, Garland, CF, Gorham, ED, Lappe, JM & Heaney, RP 2018, 'Correction: Serum 25-hydroxyvitamin D concentrations 40 ng/ml are associated with >65% lower cancer risk: Pooled analysis of randomized trial and prospective cohort study (PLoS ONE (2016) 11: 4 (e0152441) DOI: 10.1371/journal.pone.0152441)', PLoS One, vol. 13, no. 7, e0201078. https://doi.org/10.1371/journal.pone.0201078

McDonnell SL, Baggerly C, French CB, Baggerly LL, Garland CF, Gorham ED et al. Correction: Serum 25-hydroxyvitamin D concentrations 40 ng/ml are associated with >65% lower cancer risk: Pooled analysis of randomized trial and prospective cohort study (PLoS ONE (2016) 11: 4 (e0152441) DOI: 10.1371/journal.pone.0152441). PLoS One. 2018 Jul 1;13(7). e0201078. https://doi.org/10.1371/journal.pone.0201078

McDonnell, Sharon L. ; Baggerly, Carole ; French, Christine B. ; Baggerly, Leo L. ; Garland, Cedric F. ; Gorham, Edward D. ; Lappe, Joan M. ; Heaney, Robert P. / Correction : Serum 25-hydroxyvitamin D concentrations 40 ng/ml are associated with >65% lower cancer risk: Pooled analysis of randomized trial and prospective cohort study (PLoS ONE (2016) 11: 4 (e0152441) DOI: 10.1371/journal.pone.0152441). In: PLoS One. 2018 ; Vol. 13, No. 7.

@article{51a3294e352744fa831bfd978bbdf3d8,

title = "Correction: Serum 25-hydroxyvitamin D concentrations 40 ng/ml are associated with >65{\%} lower cancer risk: Pooled analysis of randomized trial and prospective cohort study (PLoS ONE (2016) 11: 4 (e0152441) DOI: 10.1371/journal.pone.0152441)",

abstract = "The Data Availability statement for this paper is incorrect. The correct statement is: The data are available through the Zenodo repository and can be accessed at https://doi.org/10.5281/zenodo.1299364.",

author = "McDonnell, {Sharon L.} and Carole Baggerly and French, {Christine B.} and Baggerly, {Leo L.} and Garland, {Cedric F.} and Gorham, {Edward D.} and Lappe, {Joan M.} and Heaney, {Robert P.}",

year = "2018",

month = "7",

day = "1",

doi = "10.1371/journal.pone.0201078",

language = "English (US)",

volume = "13",

journal = "PLoS One",

issn = "1932-6203",

publisher = "Public Library of Science",

number = "7",

}

TY - JOUR

T1 - Correction

T2 - Serum 25-hydroxyvitamin D concentrations 40 ng/ml are associated with >65% lower cancer risk: Pooled analysis of randomized trial and prospective cohort study (PLoS ONE (2016) 11: 4 (e0152441) DOI: 10.1371/journal.pone.0152441)

AU - McDonnell, Sharon L.

AU - Baggerly, Carole

AU - French, Christine B.

AU - Baggerly, Leo L.

AU - Garland, Cedric F.

AU - Gorham, Edward D.

AU - Lappe, Joan M.

AU - Heaney, Robert P.

PY - 2018/7/1

Y1 - 2018/7/1

N2 - The Data Availability statement for this paper is incorrect. The correct statement is: The data are available through the Zenodo repository and can be accessed at https://doi.org/10.5281/zenodo.1299364.

AB - The Data Availability statement for this paper is incorrect. The correct statement is: The data are available through the Zenodo repository and can be accessed at https://doi.org/10.5281/zenodo.1299364.

UR - http://www.scopus.com/inward/record.url?scp=85049957174&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049957174&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0201078

DO - 10.1371/journal.pone.0201078

M3 - Comment/debate

VL - 13

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 7

M1 - e0201078

ER -

Access to Document

10.1371/journal.pone.0201078